Iowa City, IA 52242
BS, Summa cum Laude, McMaster University
MD, Honors, University of Toronto
MSc, University of Toronto and The Samuel Lunenfeld Research Institute
Residency, General Surgery, University of Toronto
Fellowship, Endocrine Surgical Oncology, Mt. Zion Medical Center, University of California, San Francisco
Licensure and Certifications
Iowa Medical License, Iowa Board of Medical Examiners
Board Certified, General Surgery, American Board of Surgery
Royal College of Physicians and Surgeons of Canada
Geeta Lal Surgical Oncology Laboratory- http://www.medicine.uiowa.edu/lallab/
Lal G, Groff M, Howe J, Weigel , Sugg S, Lynch C. Risk of second primary thyroid cancer following another malignancy: Trends in a population-based study. Ann Surg Oncol . 2012 January.
Lal G, Spanheimer P, Sugg S, Howe J, Weigel R. Surveillance and intervention following thyroid lobectomy. Ann Surg Oncol . 2011 June. 18(6):1729-33.
Lal G, Fang S. Parathyroid cancer. Endocr Pract. 2011 April. 1:36-43.
Lal G, Weigel R, Kirby P, Miron , Royer N. Incidental finding of Composite pheochromocytoma-ganglioneuroma: Successful management after emergent appendectomy and review of the literature.. World Journal of Endocrine surgery . 2011. 3(1):34-44.
Lal G, Clark O. Management of Differentiated Thyroid cancers – Updated guidelines from the American Thyroid Association. 2010 December.
Lal G, Gardner D, Greenspan F, Clark O. Endocrine Surgery. McGraw-Hill Companies. 2010.
Lal G, Fairchild , Howe J, Weigel R, Sugg S, Menda Y. PET-CT for recurrent or persistent differentiated thyroid cancer – Is there added utility beyond conventional imaging? . Surgery. 2010. 148(6):1082-9.
Lal G, Weigel , Fang S, Guidroz J, O’Malley , Sugg , Howe J. Expansion of a cell population expressing Stem cell markers in parathyroid glands from patients with Hyperparathyroidism. Ann Surg. 2010 January. 251(1):107-13.
Lal G, Nowell A, Liao J, Sugg , Weigel R, Howe J. Determinants of survival in patients with calciphylaxis – a multivariate analysis. Surgery. 2009 December. 146(6):1028-34.
Lal G, Hashimi , Smith B, Zhang L, Lynch , Robinson R, Weigel . Extracellular Matrix 1 (ECM1) expression is a novel prognostic marker for poor long-term survival in breast cancer – a hospital-based cohort study in Iowa. Ann Surg Oncol ; 2009.